Skinuvita
Bremen
About Skinuvita
Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims to improve the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: Seed
- Last round: Seed (Jul 2024)
- Website: skinuvita.de
- Phone: [email protected]
Industries & Categories
Health Care, Personal Health, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/skinuvita-41656 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.